Pds biotech to present at h.c. wainwright 26th annual global investment conference

Princeton, n.j., sept. 03, 2024 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today announced that frank bedu-addo, phd, president and chief executive officer of pds biotech will present at the h.c. wainwright 26th annual global investment conference taking place september 9-11, 2024 in new york city.
PDSB Ratings Summary
PDSB Quant Ranking